NCT06926166 Human Genes and Microbiota in Early Life
| NCT ID | NCT06926166 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Guangzhou Women and Children's Medical Center |
| Condition | Host and Microbiome |
| Study Type | OBSERVATIONAL |
| Enrollment | 20,000 participants |
| Start Date | 2019-04-01 |
| Primary Completion | 2038-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 20,000 participants in total. It began in 2019-04-01 with a primary completion date of 2038-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The long-term goal of the Human Genes and Microbiota in Early Life (HuGME) is to explore the short- and long-term effects of maternal microbiota during pregnancy and the microbiota colonization of their offspring early in life and their interaction with the host on maternal-offspring health consequences in later life in the born in Guangzhou cohort study in China. Identification of the effect of microbiota in early life, as well as environmental factors and microbe-host interaction, will lead to a better understanding of disease pathogenesis and provide a foundation for targeted mechanistic investigation into the consequences of microbial-host crosstalk for long-term health. It also can result in new strategies to predict and prevent diseases in later life.
Eligibility Criteria
Inclusion Criteria: Pregnant women with \< 20 weeks of gestation Pregnant women intended to eventually deliver in Guangzhou Women and Children's medical center Permanent residengts of families intended to remain in Guangzhou with their child for ≥3 years Exclusion Criteria: Refuses to have blood and stool samples stored at Born in Guangzhou cohort study Biobank.
Contact & Investigator
Xiu Qiu, PhD
PRINCIPAL INVESTIGATOR
Study Principal Investigator Guangzhou Women and Children's Medical Center, China
Frequently Asked Questions
Who can join the NCT06926166 clinical trial?
This trial is open to participants of all sexes, studying Host and Microbiome. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06926166 currently recruiting?
Yes, NCT06926166 is actively recruiting participants. Contact the research team at qxiu0161@163.com for enrollment information.
Where is the NCT06926166 trial being conducted?
This trial is being conducted at Guangzhou, China.
Who is sponsoring the NCT06926166 clinical trial?
NCT06926166 is sponsored by Guangzhou Women and Children's Medical Center. The principal investigator is Xiu Qiu, PhD at Study Principal Investigator Guangzhou Women and Children's Medical Center, China. The trial plans to enroll 20,000 participants.